Building on the wide range of products available from DiaSorin for stool diagnostics, with each DiaSorin LIAISON® Ixt/Arrow™ instrument purchased during February 2014, DiaSorin is providing 2000€ ...
October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...
A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily ...
Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide, with early detection critical for improving clinical outcomes. In Denmark’s CRC screening program, ...